Search Results 1561-1570 of 21323 for anti-TNF drugs

1. Undifferentiated pleomorphic sarcoma - Symptoms and causes - Mayo Clinic

   Learn about this cancer that most often happens in the soft tissues of the arms and legs. Treatments include surgery, radiation therapy and chemotherapy.

2. Patient and Visitor Guide - Mayo Clinic

   The Mayo Clinic Patient & Visitor Guide is your starting point for your first or next visit.

3. Pegfilgrastim (Subcutaneous Route) Description and Brand Names - Mayo Clinic

   When certain cancer medicines are used to fight cancer cells, they also affect the white blood cells that fight infections. Pegfilgrastim is used to reduce ...

4. A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas - Mayo Clinic

   ... therapy and previously exposed to brentuximab vedotin and anti-PD1;; All other subtypes: following at least 2 prior lines of therapy;; Subjects previously ...

5. Torsemide (Oral Route) Proper Use - Mayo Clinic

   In addition to the use of the medicine your doctor has prescribed, treatment for your high blood pressure may include weight control and care in the types of ...

6. Clinical Trials - Division of Infectious Diseases

   Traditional treatment involves surgery followed by six weeks of daily radiation therapy. This study investigates a less intense radiation treatment following ...

7. Tranexamic Acid (Intravenous Route) Before Using - Mayo Clinic

   ... medicines. Anti-Inhibitor Coagulant Complex; Chlorpromazine; Tretinoin. Other Interactions. Certain medicines should not be used at or around the time of eating ...

8. Eculizumab (Intravenous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

9. New progress in development of gene therapy for arthritis - Mayo Clinic

   Treatment of arthritis is limited by the pharmacokinetics of joints, which impede the sustained, intra-articular delivery of therapeutic agents.

10. A Study of APR-246 and Pembrolizumab in Patients with Solid Tumor Malignancies - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Prior treatment with anti-PD1/anti-PD-L1 therapy is prohibited;; Patients ...